Associate Vice Provost for Research & CCT Exec. Dir.: John Swartley	Print Issue
,

Dr. Swartley has been part of the CTT leadership team since 2007, serving as Interim Executive Director, Deputy Executive Director, and Senior Director and Head of New Ventures.  Working closely with the Vice Provost for Research and the CTT’s Executive Director, Dr. Swartley has helped to oversee CTT’s technology commercialization efforts, new venture formation, and translational innovation activities based on Penn discoveries and faculty expertise.  He led the establishment and launch of CTT’s UPstart Company Formation Program, a groundbreaking new model for University venture creation.

“John Swartley has been a key partner in all of CTT’s considerable achievements over the past six years,” said Provost Price.  “Vice Provost Bonnell and I are confident that he is the ideal leader to advance that critical mission in the years ahead.  We are most grateful to Dean Steven Fluharty, formerly the Senior Vice Provost for Research, and the search committee he chaired, whose invaluable work led to this outstanding result.”

Prior to joining Penn, Dr. Swartley was Senior Vice President and General Partner of BCM Technologies, the venture capital subsidiary of Baylor College of Medicine, and Associate Director of the Office of Cooperative Research at Yale University.  He earned an MBA (1997) and a PhD (1993) in microbiology and molecular genetics from Emory University and a BS cum laude (1988) in biology from Bates College. 

The Center for Technology Transfer supports economic growth by forging closer ties with industry and launching new ventures based on Penn technology; provides a comprehensive technology transfer system to Penn faculty; commercializes Penn research discoveries for societal benefit; and generates income for future research, development and education. Dr. Swartley, who served as Interim Executive Director since February 1, 2013, succeeds Dr. Michael J. Cleare, who retired from Penn on January 31, 2013.